Clinical Trials List
Protocol NumberD9727C00001
Not yet recruiting
2025-09-15 - 2036-04-30
Phase III
Recruiting3
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳俊德 Division of Hematology & Oncology
- 范綱行 Division of Hematology & Oncology
- 陳東藝 Division of Hematology & Oncology
- Kai-Jie Yu Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- 張鈞弼 Division of Hematology & Oncology
- Jing-Ren Tseng Division of Hematology & Oncology
- PO-HUNG LIN Division of Hematology & Oncology
- 張境夫 Division of Hematology & Oncology
- 詹頂立 Division of Hematology & Oncology
- Hong-Cheng Gan Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
- Rita cheng Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chia-Hsien Chen Division of Urology
- YEN-HENG LIN Division of Urology
- CHING-CHU LU Division of Urology
- YU-CHUAN LU Division of Urology
- JIAN-HUA HONG Division of Urology
- Yeong-Shiau Pu Division of Urology
- 王中傑 Division of Urology
- 呂紹綸 Division of Urology
- 張尚仁 Division of Urology
- 藍耿學 Division of Urology
- 王嘉儁 Division of Urology
- PO-MING CHOW Division of Urology
- - - Division of Urology
- 闕士傑 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
36 participants
-
Global
700 participants
